Former Teams
Publications
Download- 
													
	2025Towards Improved Peptidic α-Ketoamide Inhibitors of the Plasmodial Subtilisin-Like SUB1: Exploration of N-Terminal Extensions and Cyclic Constraints., ChemMedChem 2025 Jan; (): e202400924.
- 
													
	2024Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1., Eur J Med Chem 2024 Apr; 269(): 116308.
- 
													
	2022Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetes., Sci Rep 2022 07; 12(1): 12077.
- 
													
	2021Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions., Ann Diagn Pathol 2021 Aug; 53(): 151766.
- 
													
	2020Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population., Endocrine 2020 Sep; (): .
- 
													
	2020Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases., Biochim Biophys Acta Mol Basis Dis 2020 06; 1866(6): 165716.
- 
													
	2020Molecular Target Validation of Aspartate Transcarbamoylase from Plasmodium falciparum by Torin 2., ACS Infect Dis 2020 05; 6(5): 986-999.
- 
													
	2020A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosa., Int J Biol Macromol 2020 Mar; 146(): 212-221.
- 
													
	2020New directions in antimalarial target validation., Expert Opin Drug Discov 2020 02; 15(2): 189-202.
- 
													
	2019Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparum., Microbiologyopen 2019 Feb; (): e779.
- 
												
													+View full list of publications

 
																	